An inflammatory cytokine signature predicts COVID-19 severity and survival
2020 · Nature Medicine · 2,683 citations
https://doi.org/10.1038/s41591-020-1051-9
M
Madhu Mazumdar
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
391
Papers
27.8K
Citations
84
h-index
204
i10-index
Madhu Mazumdar is an academic researcher from University of Delhi. The author has contributed to research in topics: Renal cell carcinoma treatment & Bladder and Urothelial Cancer Treatments & Urinary and Genital Oncology Studies. The author has an h-index of 84, co-authored 333 publications.
ORCID: 0000-0003-3965-5146Papers by this author
worksTERATOMA WITH MALIGNANT TRANSFORMATION: DIVERSE MALIGNANT HISTOLOGIES ARISING IN MEN WITH GERM CELL TUMORS
1998 · The Journal of Urology · 432 citations
https://doi.org/10.1016/s0022-5347(01)64035-7
Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma.
1997 · Journal of Clinical Oncology · 375 citations
https://doi.org/10.1200/jco.1997.15.5.1853
Association of Multimodal Pain Management Strategies with Perioperative Outcomes and Resource Utilization
2018 · Anesthesiology · 201 citations
https://doi.org/10.1097/aln.0000000000002132
Sleep Apnea and Total Joint Arthroplasty under Various Types of Anesthesia
2013 · Regional Anesthesia & Pain Medicine · 122 citations
https://doi.org/10.1097/aap.0b013e31828d0173
Comparison of statistical and machine learning models for healthcare cost data: a simulation study motivated by Oncology Care Model (OCM) data
2020 · BMC Health Services Research · 47 citations
https://doi.org/10.1186/s12913-020-05148-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat